Conjunctivitis is a common condition that causes redness and swelling of the thin layer of tissue that covers the front of the eye (conjunctiva). It is most common in babies older than three months.

Aldesleukin is under clinical development by Iltoo Pharma and currently in Phase II for Allergic Rhino-Conjunctivitis.

It is a subcategory of MMP and can lead to permanent vision loss if a person does not receive treatment. The disease causes chronic and relapsing conjunctivitis in both eyes. OCP occurs as a ...

LONDON, GB / ACCESSWIRE / January 9, 2025 / Nanomerics Ltd., a private speciality pharmaceutical company today announced that it had completed 28 consecutive days of administration in its OC134 Phase ...

"For allergic conjunctivitis, the most effective treatment is avoidance of the offending exposure." ...

A Canadian teen's severe bird flu infection has highlighted growing concerns about the H5N1 virus, commonly known as ...

The teams published their reports today in the New England Journal of Medicine ( NEJM ).